Diagnostic Respiratory -
Drug Delivery and
Diagnostic Systems
Inhaling the right medicine dosage upon the airway obstruction at any given time.
Personalized adjusted treatment for Asthma and COPD for better bioavailability and lungs disposition.
About Us
 AsMedic Ltd. was founded in 2005 purposing to develop and disseminate in the market unique and innovative delivery and diagnostic systems in the respiratory field.
AsMedic is owned by its founders and a pharmaceutical company. The majority of its funding was done by the founders, a pharmaceutical company and the Israel Innovative Authority – a governmental organization.
The Market
600-700 Million
Asthma & COPD patients
About 30%
Should Use daily preventive drugs
500-600 Million
Annual inhalers sold
$25 Billion
Annual market size
The Products
Personalized flow sensor-based inhalers incorporating spirometer-like features to adjust the drug dosage according to the patient’s airway obstruction at any given moment.
The Team
Arie Huber
CEO
Professor Paltiel Weiner
Medical Manager
Dr Shraga Haber
CTO
Dr Gabor (Gaby) Kosa
Technical Advisor